Tag Archives: Vivus

Belviq's Battle of the Bulge

Arena Pharmaceuticals’ and marketing partner Eisai’s Belviq – the first FDA-approved drug to treat obesity in over a decade – is making progress with payers and beefing up sales forces to target primary care physicians. DTC support began in September. Perhaps the most significant development in obesity of late is the recognition by payers – […]
Posted in Advertising, FDA, Global, healthcare, Market Access, Marketing, Patient Communication, People, pricing, Regulatory, Safety, Sales, Strategy | Also tagged , , , , , , , , , , , , , | Leave a comment

Activism Is A Bitter Pill More Healthcare Companies May Have To Swallow

by Barbara Ryan In the next three months it is likely that three healthcare companies will face crucial activist votes.  At Alere Inc., Coppersmith Capital Management, LLC wants the company to sell/divest assets which it believes could allow them to pay down over $3B in debt.  In response, Alere is mounting a Hess style defense, […]
Posted in Biotech, Corporate Responsibility, healthcare, leadership, Legal, Strategy | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta